Posted 21 days ago

Company overview

Nuclera is a biotechnology company specializing in eProtein and eDNA synthesis technologies, enabling rapid and on-demand production of proteins and DNA for research and therapeutic applications. Founded in 2013 and headquartered in Cambridge, UK, the company focuses on streamlining workflows for scientists in life sciences, pharmaceuticals, and synthetic biology. Nuclera generates revenue by offering its proprietary benchtop bioprinter systems and consumables, designed to accelerate molecular biology processes. The company has also secured significant funding and partnerships, including collaborations with industry leaders, to advance its innovative solutions.